WeVote

Bill

Bill

A 6439

Requires that the siting, construction and establishment of methadone program facilities in New York city be proportionately dispersed in the boroughs of such cities

2025 Regular Session Introduced by George Alvarez and 5 co-sponsors

Requires proportional dispersal of NYC methadone facilities across boroughs, aiming for geographic equity; affects providers' siting plans and residents' access to treatment.

REFERRED TO ALCOHOLISM AND DRUG ABUSE
0
WeVote Research Nonpartisan
Bill Summary · A 6439

Summary of Assembly Bill A 6439 (New York)

Overview

  • Bill Number: A 6439
  • Title: Requires that the siting, construction and establishment of methadone program facilities in New York City be proportionately dispersed in the boroughs of such city
  • Status: Referred to the Assembly Committee on Alcoholism and Drug Abuse
  • Introduced: March 4, 2025
  • Classification: Bill (Assembly)

Purpose and Intent

  • The bill seeks to ensure that the siting, construction, and establishment of methadone program facilities in New York City are proportionately dispersed across the city’s boroughs.
  • In practical terms, this would aim to prevent clustering of facilities in a single borough and promote more even distribution to reflect NYC’s diverse borough populations and needs.

Key Provisions (as indicated by title and summary)

  • The central requirement is a proportional dispersion rule for methadone program facilities within New York City’s five boroughs (Manhattan, Brooklyn, Queens, The Bronx, and Staten Island).
  • The bill would govern where facilities may be established, emphasizing geographic distribution, potentially tied to population or need metrics (though the exact dispersion standard is not specified in the provided information).

Note: The available information does not include the full text, so specific operational details (e.g., how “proportionate” is defined, metrics used, transition timelines, enforcement mechanisms) are not available here.

Who Is Affected

  • Methadone treatment providers and operators in New York City, who would need to site new facilities in accordance with the dispersion requirement.
  • New York City residents seeking methadone treatment, who may experience changes in access based on facility locations.
  • Local governments and planning bodies responsible for siting authorization and regulatory compliance within NYC.

Procedural and Timeline Aspects

  • Introduced: March 4, 2025.
  • Committee Action: Referred to the Assembly Committee on Alcoholism and Drug Abuse on March 4, 2025 (duplication noted in the provided actions).
  • No further legislative actions are listed in the provided data.

Sponsors

  • Primary Sponsor: Amanda Septimo
  • Cosponsors: Jo Anne Simon, Brian Cunningham, George Alvarez, Keith Brown, Amy Paulin

Related Legislation

  • Assembly: A 9345 (prior-session), A 2260 (prior-session)
  • Senate (companion): S 6477 (listed as companion)

Potential Impacts and Considerations

  • Access and Equity: Aims to improve geographic equity of methadone treatment across NYC’s boroughs.
  • Operational Effects: Could require providers to adjust siting plans, coordinate with local planning authorities, and undertake borough-level distribution analyses.
  • Implementation Timeline: No timeline details are provided; would likely be clarified in the bill’s full text and subsequent committee actions.

This summary reflects the information available from the bill’s summary and status as of the provided records. For precise language, definitions, and implementation details, the full bill text and committee reports would be needed.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.